INSPAN LLC (a private company wholly owned by KICVentures Group LLC) is excited to announce that eight abstracts will be presented at the January 13-15, 2022 NANS Annual Meeting in Orlando by leading pain management physicians who are experts in outpatient interventional spine surgery. “This large number of scientific abstracts on a single device for interventional spine surgery validates Inspan as a medical technology that is being adopted by pain management physicians and by the leading pain management and neuromodulation societies such as NANS” said Dr Kingsley R Chin, the inventor of Inspan and a leading board-certified professor of orthopedic spine surgery. “The Inspan device has produced successful results and is easy to use and reliable,” said Dr Soubrata V Raikar, a leading pain management physician and one of the lead authors on an abstract to be presented at NANS. "Inspan is a minimal invasive approach that is advancing my practice as an interventional pain physician" said Dr Michael Esposito who is presenting his Inspan clinical results at NANS. Inspan also received FDA clearance in 2021 to treat spinal stenosis in addition to fusion from T1-S1 and therefore pain management doctors can now use Inspan more broadly and go head-to-head with Vertiflex. Unlike Vertflex which is an interspinous extension block design, the Inspan device fixates the spine to allow for immediate stability, distraction, decompression, and fusion from T1-S1.